B of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsDowngradesPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
B of A Securities analyst Joshua Dennerlein downgrades National Health Investors (NYSE:NHI) from Buy to Underperform and lowers the price target from $86 to $67.
B of A Securities analyst Joshua Dennerlein downgrades National Health Investors (NYSE:NHI) from Buy to Underperform and lowers the price target from $86 to $67.
